BIO-ENGINEERED STENT MARKET ANALYSIS

Bio-engineered Stent Market, by Application Type (Coronary Artery Disease, Peripheral Arterial Disease, Carotid Artery Disease, Renal Artery Stenosis, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Others), by Product Type (Drug-eluting Stents, Bioabsorbable Stents, and Drug-eluting Balloons), by Mode of Delivery (Balloon-expandable Stents and Self-expanding Stents), by Material Type (Metal-based and Polymer-based), by End User (Hospitals & Cardiac Centers and Ambulatory Surgical Centers, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights and Forecast to 2026

Published In : Feb 2019
Code : CMI2484
Pages :176
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

However, availability of alternatives for the treatment of cardiac diseases, product recalls and failure, and stringent regulations for product approvals are expected to hinder the market growth. For instance in November 2017, Abbott recall Class 1 Device Recall Absorb Bioresorbable Vascular Scaffold (BVS) System, a absorbable coronary drug-eluting stent due to elevated rates of major adverse events, specifically, myocardial infraction and scaffold thrombosis when compared to patients treated with the Xience metallic drug eluting stent.

BIO-ENGINEERED STENT MARKET ANALYSIS

Market Challenges And Opportunities

Bio-engineered Stent Market Report Snapshots

EXISTING CLIENTELE